Oorsprong van het eerstegraads netwerk van Ian Ragan
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
26
| Non-Profit Organization | Miscellaneous Commercial Services | 26 |
Nc3rs
 Nc3rs Miscellaneous Commercial ServicesCommercial Services Nc3rs operates as a scientific non-profit organization dedicated to replacing, refining, and reducing the use of animals in research and testing. The firm collaborates with scientists and organizations from across the life sciences sector including universities, the pharmaceutical, chemical, and consumer products industries, other research funders, and regulatory authorities. The company is headquartered in London, the United Kingdom.
14
| Non-Profit Organization | Miscellaneous Commercial Services | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ian Ragan via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Chief Executive Officer President | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Chief Executive Officer Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
| GALAPAGOS NV | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALMIRALL, S.A. | Pharmaceuticals: Major | Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Officer/Principal | |
| GN STORE NORD A/S | Telecommunications Equipment | Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Founder | |
| MAUNA KEA TECHNOLOGIES | Medical Specialties | Director/Board Member | |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
Acteon SA
 Acteon SA MiscellaneousMiscellaneous Acteon SA provides dental equipment, imaging, and consumables. The firm offers ultrasonic generators, video cameras, and intra oral video and medical endoscope systems. It designs solutions for dental chair and integrator manufacturers in the form of modules. The company was founded in 1946 and is headquartered in Merignac, France. | Miscellaneous | Chief Executive Officer | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Chairman Corporate Officer/Principal Director/Board Member | |
| Leem | Founder Director/Board Member | ||
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | Founder | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| VEXIM | Medical Specialties | Director/Board Member | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Chairman | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member President | |
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Pharmaceuticals: Major | Sales & Marketing | |
Financière Acteon SAS
 Financière Acteon SAS Medical SpecialtiesHealth Technology Financière Acteon SAS operates as a holding company. Its products include ultrasonic, airpolisher, surgery, polymerization, rotary instrumentation, three dimensional panoramic imaging, intraoral x-ray, imaging software, digital x-ray, diagnostic camera, gingival retraction, hygiene, endodontics, impression, and bone graft. The company was founded on November 23, 2005 and is headquartered in Merignac, France. | Medical Specialties | Chief Executive Officer | |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Wallon Institute for Life Lead Sciences | Director/Board Member Director/Board Member | ||
| Institut Supérieur des Affaires | College/University | Masters Business Admin | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman Director/Board Member | |
| Biotech Research & Innovation Centre | Chairman | ||
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Investment Managers | Chief Executive Officer | |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman | |
| MONSENSO A/S | Internet Software/Services | Director/Board Member | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
| Denemarken | 11 |
| Frankrijk | 11 |
| Verenigde Staten | 10 |
| Zwitserland | 5 |
| België | 5 |
Sectoraal
| Health Technology | 33 |
| Finance | 5 |
| Commercial Services | 4 |
| Consumer Services | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 207 |
| Corporate Officer/Principal | 108 |
| Chairman | 70 |
| Chief Executive Officer | 58 |
| Independent Dir/Board Member | 42 |
Sterkste connecties
| Insiders | |
|---|---|
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Joseph Jimenez | 32 |
| Dieter Weinand | 32 |
| Marc M. P. de Garidel | 31 |
| Ian Read | 29 |
| Ulf Arne Wiinberg | 26 |
| Peter Andersen | 26 |
| Stephen Holgate | 24 |
| Stefan Oschmann | 23 |
| Andreas Fibig | 21 |
| Jean-Christophe Tellier | 16 |
| Kim Stratton | 14 |
| Martin Hermanus Soeters | 14 |
| Giovanni Caforio | 13 |
| Lars Fruergaard Jorgensen | 13 |
